Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 12, 2010Microbial Drug Resistance

Daptomycin and Rifampin for the Treatment of Methicillin-Resistant Staphylococcus aureus Septic Pulmonary Emboli in the Absence of Endocarditis

View Full Paper
Ask AI
Bookmark
Share

Authors

EGEric GomezBrandeis UniversityAJAhmar JafaryLDLisa L. DeverRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gomez et al. (2010) studied this question.

synapsesocial.com/papers/6aa0c5257664acf805f7a19ehttps://doi.org/10.1089/mdr.2010.0001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus2005 · 241 citations
  2. 2Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐Susceptible Staphylococcus aureus Bacteremia: A Meta‐analysis2003 · 1,971 citations
  3. 3Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact2005 · 544 citations
  4. 4Pulmonary Manifestations in Children with Invasive Community-Acquired Staphylococcus aureus Infection2005 · 282 citations
  5. 5Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates2008 · 113 citations